Prevalence of Oral Manifestations of Iron Deficiency Anemia in a Sample of Egyptian Population

Prevalence of Oral Manifestations of Iron Deficiency Anemia in a Sample of Egyptian Population, Hospital-based Cross-sectional Study

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT03365570

Enrollment

180

Registered

2017-12-07

Start date

2018-05-01

Completion date

2018-11-09

Last updated

2019-01-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Iron Deficiency Anemia

Keywords

hemoglobin, iron, oral lesions, oral manifestations,cross-sectional study

Brief summary

According to WHO Reportin 2002, iron deficiency anemia was considered to be the most important contributing factor to the global burden of anemia. Children and women in reproductive ages are more at risk factor for developing iron deficiency anemia.No previous study has been held to assess prevalence of oral manifestations of iron deficiency anemia as a hospital-based cross-sectional study on a sample of Egyptian patients in hematology department (no previous data recorded).

Detailed description

Study will be held in at the Hematology department at El Qasr Al-Einy Cairo University Hospital data collection started from February 2018 till end of April 2018 primary completion. Clinical examination performed for oral mucosa, the number and type of lesions will be recorded. Patients' age, sex, duration of illness, type of anemia, location of any oral lesion or abnormality, history of drug and alcohol consumption, and presence or absence of dentures, will be recorded participants will not followed up and data will be collected prospectively. A copy of participant's blood record will be obtained from the hematology department upon its approval. Participants: Egyptian patients diagnosed with Iron deficiency anemia that attending the Hematology department at El Qasr Al-Einy Cairo University Hospital will be enrolled in the study. The age of participant enroll will be up to 70 years old, males and females will be included. For each eligible participant, a full history will be obtained according to an assessment sheet, followed by clinical examination which will be done through an interview between the investigator and the patient. All participants will be asked to sign a study-related informed consent. Oral manifestations of these patients will be evaluated by an oral medicine master student (the investigator).

Interventions

None listed

Study design

Observational model

ECOLOGIC_OR_COMMUNITY

Time perspective

CROSS_SECTIONAL

Eligibility

Sex/Gender

ALL

Age

No minimum to 70 Years

Healthy volunteers

Yes

Inclusion criteria

1. Patients diagnosed with iron deficiency anemia based on their blood tests. 2. Age: by maximum 70 years old. 3. Males and females will be included.

Exclusion criteria

1. Patients suffering from any other systemic diseases known to influence oral and maxillofacial manifestations will be excluded. 2. Patients suffering from any other systemic diseases known to cause IDA as secondary condition will be excluded. 3. Patients on drug therapy that may have oral mucosal manifestations. 4. Lesions appear because of existing local factors for example traumatic ulcer on the tongue because of sharp tooth against tongue, angular cheilitis because of poor denture design and older age patients. 5. Inflammatory diseases, malignancy, or recent surgery were excluded.

Design outcomes

Primary

Measure	Time frame	Description
Prevalence of oral mucosal lesions	15 minutes	Presence of oral mucosal lesions will be assessed by clinical picture into dichotomous outcome (Yes/No) and percentage of each.

Countries

Egypt

Outcome results